The Metabolic Disease Faculty Practice Associates at The Mount Sinai Medical Center provides the best possible care for patients with endocrinological diseases and metabolic diseases. These patients include those with diseases of the thyroid, parathyroid, pituitary gland, gonads, and adrenal glands as well as diseases of the pancreas and all forms of diabetes, osteoporosis, and metabolic bone diseases. As well as its mission of patient care, the practice is also at the forefront of medical education, teaching students the concepts of endocrine and metabolic physiology and pathophysiology. Its educational mission includes educating patients with endocrine and metabolic diseases so that they understand their problems and are able to seek appropriate care and treatment wherever they may be. The practice also conducts research into the mechanisms underlying the normal physiology and pathophysiology of the endocrine glands and metabolic disorders in order to provide new insights for future therapies, in addition to raising funds to help the division achieve these goals in clinical care, education, and research. Every physician in Metabolic Disease Faculty Practice Associates is a staff member of the Mount Sinai Hospital and the Icahn School of Medicine.
Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles
May 24, 2013 - The new agreement was negotiated through Blue Mountain Technologies, a program of Mount Sinai Innovation Partners.
Ketamine Shows Significant Benefit in People with Treatment-Resistant Depression
May 20, 2013 - Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic.
The Metabolic Disease FPA is open from 9 A.M. until 5 P.M., Monday through Friday.